Article Information
History
- December 9, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Pille Hallast1,2,*,
- Laura Kibena1,
- Margus Punab3,4,
- Elena Arciero2,
- Siiri Rootsi5,
- Marina Grigorova1,
- Rodrigo Flores5,
- Mark A. Jobling6,
- Olev Poolamets3,
- Kristjan Pomm3,
- Paul Korrovits3,
- Kristiina Rull1,4,7,
- Yali Xue2,
- Chris Tyler-Smith2 and
- Maris Laan1,*
- 1Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, 50411, Estonia
- 2Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK
- 3Andrology Unit, Tartu University Hospital, Tartu, 50406, Estonia
- 4Institute of Clinical Medicine, University of Tartu, Tartu, 50406, Estonia
- 5Institute of Genomics, Estonian Biocentre, University of Tartu, Tartu, 51010, Estonia
- 6Department of Genetics & Genome Biology, University of Leicester, Leicester, LE1 7RH, UK
- 7Women’s Clinic, Tartu University Hospital, Tartu, 50406, Estonia
- ↵*Corresponding authors: Pille Hallast, pille.hallast{at}ut.ee; Tel: +372 737 5009, Maris Laan, maris.laan{at}ut.ee; Tel: +372 737 5008
Posted December 09, 2020.
A common 1.6 Mb Y-chromosomal inversion predisposes to subsequent deletions and severe spermatogenic failure in humans
